THREE HEALTHCARE SYSTEMS CHOOSE FUJIFILM TO ENHANCE DIAGNOSTIC IMAGING CAPABILITIES
Stamford, CT, September 18, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging solutions with a comprehensive portfolio of digital radiography (DR) and mammography solutions, today announced that it has closed new contracts to enhance diagnostic imaging capabilities for existing customers across the United States. Three healthcare systems will implement Fujifilm’s imaging solutions including, mobile DR systems (FDR Go), the newest DR detector (FDR D-EVO II), DR rooms (FDR Clinica Series of Components) and Fujifilm’s newest mammography solution, the ASPIRE Cristalle with Digital Breast Tomosynthesis (DBT) to provide enhanced diagnostic accuracy and improved patient experience.
“Fujifilm is thrilled to be the imaging partner for our longstanding health provider customers across the United States,” said Rob Fabrizio, Director of Strategic Marketing, Digital Radiography and Women’s Health, FUJIFILM Medical Systems U.S.A., Inc. “With our wide range of offerings from digital radiography to enterprise imaging, customers continue to turn to Fujifilm when they need to add equipment to growing facilities or upgrade to the latest solutions.”
Fujifilm offers a complete portfolio of DR equipment including DR detectors, mobiles, rooms, mammography and advanced image processing. Fujifilm, with its heritage in imaging – as developers of the first computed radiography -- continues to innovate with exceptional image quality and renowned reliability. Healthcare systems and hospitals across the United States partner with Fujifilm for DR to achieve superior image quality and to maximize workflow efficiency.
Recently, Fujifilm collaborated with the following health providers delivering its unique imaging solutions from its DR and Women’s Health portfolios:
Assured Imaging LLC (Tucson, AZ). A leading provider of mobile digital mammography in the United States. In June 2017, Assured Imaging installed the first two ASPIRE Cristalle systems with 3D breast imaging in their imaging centers located in Scottsdale, AZ and Los Lunas, NM, of several units planned for the year.
Boston Children’s Hospital (Boston, MA). As a 404-bed comprehensive center for pediatric health care, Boston Children’s is one of the largest pediatric medical centers in the United States. In May 2017, Boston Children’s installed the world’s first single exposure long length DR Detector, the D-EVO GL long-length panel (17x49), with Fujifilm’s Virtual GridTM image processing software.
CHRISTUS Mother Frances Hospital - Tyler (Tyler, TX). A 402-bed acute care facility that offers a complete range of services including Tyler’s first neonatal intensive care unit. In June 2017, CHRISTUS Mother Frances Hospital - Tyler installed six FDR Go’s with D-EVO II detectors as well as one additional in the CMFH-Jacksonville acute care hospital.
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujifilmhealthcare.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2017, the company had global revenues of $21.5 billion, at an exchange rate of 108 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.